招商证券(香港)：给予阿里健康(00241.HK)“买入”评级目标价17.60港元

招商证券(香港)2月27日发布公告。We trimmed 2019E/20E revenue by 5%/7% to reflect epidemic impact and Co.’s effort to help government to curb the outbreak. That said, we think the short-term pressure for the long-term benefit is worthy. We thus raised SOTP-based TP to HKD17.6, to reflect our valuation rolled forward to FY20/21E basis and Co’s greater long-term promise amid deregulation. Maintain BUY on Co’s solid leading position in healthcare e-commerce, and enhancing monetization potential.

来源: 同花顺金融研究中心

【本文作者】：亿闻天下网，商业用途未经许可不得转载，非商业用途转载注明出处原文链接：https://cqsoo.com/cy/39883.html

【版权与免责声明】：如发现内容存在版权问题，烦请提供相关信息发邮件至 kefu@cqsoo.com ，

并提供相关证据，一经查实，本站将立刻删除涉嫌侵权内容。反馈给我们

本文内容由互联网用户自发贡献，本站不拥有所有权，不承担相关法律责任。